¹®¿ëÈ
Ç÷¾×Á¾¾ç³»°úÀå
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : À¯¹æ¾Ï, ºÎÀξÏ, Àü¸³¼±¾Ï
Á÷
ˤ
: ±³¼ö(Ç÷¾×Á¾¾ç³»°úÀå)
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
8
ÇØ¿Ü
Sohn JH*, Moon YW*, Lee CG, et al.. Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer. (*Both equally contributed) Cancer 109:1845-1850, 2007
7
ÇØ¿Ü
Moon YW, Jeung H-C, Rha SY, et al.. Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer. Breast Cancer Res Treat 104:31-37, 2007
6
ÇØ¿Ü
Moon YW, Jeung H-C, Rha SY, et al.. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute. Ann Surg Oncol 14:2730-2737, 2007
5
±¹³»
Moon YW, Choi ST, Cho BC, et al.. A case of successful intrapleural chemotherapy with cisplatin plus cytarabine for intractable malignant pleural effusion. Yonsei Med J 48:1035-1038, 2007
4
ÇØ¿Ü
Sohn JH, Choi HJ, Chang J, Kim SK, Lee CG, Chung KY, Kim DJ, Cho BC, Shin SJ, Moon YW, et al.. A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer. Lung Cancer 54:365-370, 2006
3
ÇØ¿Ü
Rha SY, Moon YH, Jeung H-C, et al.. Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer. Breast Cancer Res Treat 90:215-221, 2005
2
±¹³»
Moon YW, Hahn JS, Lee ST, et al.. Clinical characteristics and treatment outcome of primary mediastinal lymphoma. Korean J Med 68:417 426, 2005 (Korean)
1
±¹³»
Moon YW, Yang H, Jung HC, et al.. Application of gabexate mesylate IC50 against MMP - 9 using ex vivo model in gastric cancer: prognostic factor and selection criteria for anti - MMP treatment. J Korean Cancer Assoc 32:7-18, 2000 (Korean)
1
2
3
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729